Dyna Pentoxifylline 400 mg Slow release FC tablet.
PDF Leaflet Revision Date: 15 December 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief of intermittent claudication and Raynaudu2019s syndrome.
Dosage (summary)
1 tablet 2-3 times daily after meals.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Antihypertensive medicines
- Anticoagulants
- Theophylline
- Ciprofloxacin
- Ketorolac
Contraindications
- Hypersensitivity to pentoxifylline
- Cerebral haemorrhage
- Severe cardiac dysrhythmias
- Acute myocardial infarction
- Porphyria
Common side effects
- Dizziness
- Nausea
- Vomiting
- Hypotension
- Thrombocytopenia
Counselling Points
- Take after meals with liquid.
- Monitor for signs of bleeding.
- Avoid driving if dizzy.
Serious warnings
- Risk of bleeding
- Anaphylactic reactions
- Caution in hypotensive patients
Important Disclaimer
The Dyna Pentoxifylline 400 mg Slow release FC tablet. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
